NTSR2 and prostate carcinoma: In contrast, the low-affinity NTSR2, which shares 60% homology with NTSR1, demonstrates a more localized distribution; the expression of NTSR2 has been recently reported in prostate cancers and B cell lymphomas [6, 7].